PhRMA Prepares To Make Case For “FDA Defense” In Malpractice Bill
Executive Summary
A U.S. Chamber of Commerce survey on the impact of prescription drug product liability litigation could help the pharmaceutical industry shore up its case for inclusion of "FDA defense" language in any medical malpractice legislation enacted into law
You may also be interested in...
Rx Cost-Effectiveness Studies Should Be Part Of Medicare Bill, AARP Says
AARP wants the House/Senate Medicare conference committee to include a provision mandating federal cost-effectiveness research on pharmaceuticals
Product Liability Litigation Impeding R&D, FDA Commissioner Says
Pharmaceutical research and development is suffering because of the high cost of product liability litigation, FDA Commissioner McClellan said at a U.S. Chamber of Commerce conference in Washington, D.C. July 15
Product Liability Litigation Impeding R&D, FDA Commissioner Says
Pharmaceutical research and development is suffering because of the high cost of product liability litigation, FDA Commissioner McClellan said at a U.S. Chamber of Commerce conference in Washington, D.C. July 15